Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E. Ware, Robert J. Adams, Barry R. Davis et al.|The Lancet|2015Cited by 518
Acute Ischemic Priapism: An AUA/SMSNA GuidelineTrinity J. Bivalacqua, Nelson Bennett, Landon Trost et al.|The Journal of Urology|2021Cited by 91
The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA GuidelineTrinity J. Bivalacqua, Nelson Bennett, Bryant Allen et al.|The Journal of Urology|2022Cited by 86
Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical ReportAmber M. Yates, Ryan Hooker, Banu Aygün et al.|PEDIATRICS|2024Cited by 22
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell AnemiaRussell E. Ware, Robert J. Adams, Barry R. Davis et al.|Blood|2015Cited by 17